Media coverage about Envision Healthcare (NYSE:EVHC) has been trending somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Envision Healthcare earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.2366741390188 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news articles that may have effected Accern’s analysis:
Envision Healthcare (NYSE EVHC) traded up $1.34 during midday trading on Friday, hitting $34.30. 5,363,380 shares of the company’s stock were exchanged, compared to its average volume of 2,281,138. The stock has a market capitalization of $3,990.00, a PE ratio of 10.30, a P/E/G ratio of 0.87 and a beta of 0.57. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $73.00. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89.
Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company’s quarterly revenue was up 142.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.13 EPS. sell-side analysts forecast that Envision Healthcare will post 2.56 earnings per share for the current year.
Envision Healthcare declared that its board has initiated a share buyback program on Monday, September 18th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
A number of research firms recently commented on EVHC. BidaskClub cut shares of Envision Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 17th. Jefferies Group set a $71.00 target price on shares of Envision Healthcare and gave the company a “buy” rating in a research report on Thursday, August 24th. Bank of America decreased their target price on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, October 9th. Canaccord Genuity reissued a “buy” rating and set a $32.00 target price (down previously from $68.00) on shares of Envision Healthcare in a research report on Thursday, November 2nd. Finally, Citigroup cut shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 target price for the company. in a research report on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $46.06.
ILLEGAL ACTIVITY NOTICE: This piece was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/12/15/envision-healthcare-evhc-earning-somewhat-positive-press-coverage-study-finds.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.